Maternus-Kliniken Aktiengesellschaft (ETR:MAK)
1.310
0.00 (0.00%)
Aug 1, 2025, 5:36 PM CET
Accolade Market Cap
ETR:MAK has a market cap or net worth of €27.47 million as of August 1, 2025. Its market cap has decreased by -35.78% in one year.
Market Cap
27.47M
Enterprise Value
133.20M
Revenue
114.00M
Ranking
n/a
PE Ratio
n/a
Stock Price
$1.31
Market Cap Chart
Since February 17, 1998, ETR:MAK's market cap has decreased from 110.87M to 27.47M, a decrease of -75.22%. That is a compound annual growth rate of -4.95%.
Market Cap History
Date | Market Cap | % Change |
---|---|---|
Aug 1, 2025 | 27.47M | -3.68% |
Dec 30, 2024 | 28.52M | -52.45% |
Dec 29, 2023 | 59.97M | 71.26% |
Dec 29, 2022 | 35.02M | -65.64% |
Dec 30, 2021 | 101.91M | 10.96% |
Dec 30, 2020 | 91.85M | 114.71% |
Dec 30, 2019 | Upgrade Pro | Upgrade Pro |
Dec 28, 2018 | Upgrade Pro | Upgrade Pro |
Dec 29, 2017 | Upgrade Pro | Upgrade Pro |
Dec 30, 2016 | Upgrade Pro | Upgrade Pro |
Dec 30, 2015 | Upgrade Pro | Upgrade Pro |
Market Capitalization
Market capitalization, also called net worth, is the total value of all of a company's outstanding shares. It is calculated by multiplying the stock price by the number of shares outstanding.
Formula: Market Cap = Stock Price * Shares Outstanding
Full DefinitionRelated Stocks
Company | Market Cap |
---|---|
Siemens Healthineers AG | 54.09B |
Merck KGaA | 49.06B |
Bayer Aktiengesellschaft | 28.07B |
Fresenius SE & Co. KGaA | 23.82B |
Fresenius Medical Care AG | 13.20B |
Sartorius Aktiengesellschaft | 12.12B |
Fielmann Group AG | 4.67B |
Carl Zeiss Meditec AG | 4.38B |